Inefficacious drugs against covid-19: analysis of sales, tweets, and search engines
DOI:
https://doi.org/10.11606/s1518-8787.2024058005413Keywords:
Social Media, Chloroquine, Ivermectin, Covid-19, Search Engine, Infodemic, Pandemic, SARS-CoV-2Abstract
OBJECTIVE: Assess the correlation between the sales of two drugs with no proven efficacy against covid-19, ivermectin and chloroquine, and other relevant variables, such as Google® searches, number of tweets related to these drugs, number of cases and deaths resulting from covid-19. METHODS: Th e m ethodology a dopted i n t his s tudy h as f our s tages: d ata c ollection, d ata processing, exploratory data analysis, and correlation analysis. Spearman’s method was used to obtain cross-correlations between each pair of variables. RESULTS: The results show similar behaviors between variables. Peaks occurred in the same or near periods. The exploratory data analysis showed shortage of chloroquine in the period corresponding to the beginning of advertising for the application of these drugs against covid-19. Both drugs showed a high and statistically significant correlation with the other variables. Also, some of them showed a higher correlation with drug sales when we employed a one-month lag. In the case of chloroquine, this was observed for the number of deaths. In the case of ivermectin, this was observed for the number of tweets, cases, and deaths. CONCLUSIONS: The results contribute to decision making in crisis management by governments, industries, and stores. In times of crisis, as observed during the covid-19 pandemic, some variables can help sales forecasting, especially Google® and tweets, which provide a realtime analysis of the situation. Monitoring social media platforms and search engines would allow the determination of drug use by the population and better prediction of potential peaks in the demand for these drugs.
References
Fonseca EM, Nattrass N, Lazaro LL, Bastos FI. Political discourse, denialism and leadership failure in Brazil’s response to COVID-19. Glob Public Health. 2021;16(8-9):1251-66. https://doi.org/10.1080/17441692.2021.1945123
Furlan L, Caramelli B. The regrettable story of the “Covid Kit” and the “Early Treatment of Covid-19” in Brazil. Lancet Reg Heal – Am. 2021 Dec;4:100089. https://doi.org/10.1016/j.lana.2021.100089
Fittler A, Adeniye L, Katz Z, Bella R. Effect of infodemic regarding the illegal sale of medications on the internet: evaluation of demand and online availability of ivermectin during the COVID-19 pandemic. Int J Environ Res Public Health. 2021 Jul;18(14):7475.
https://doi.org/10.3390/ijerph18147475
Alves L. Brazilian ICUs short of drugs and beds amid COVID-19 surge. Lancet. 2021 Apr;397(10283):1431-2. https://doi.org/10.1016/S0140-6736(21)00836-9
Naeem M. Do social media platforms develop consumer panic buying during the fear of Covid-19 pandemic. J Retail Consum Serv. 2021 Jan;58:102226. https://doi.org/10.1016/j.jretconser.2020.102226
Brito Junior I, Yoshizaki HT, Saraiva FA, Bruno ND, Silva RF, Hino CM, et al. Panic buying behavior analysis according to consumer income and product type during COVID-19. Sustainability (Basel). 2023 Jan;15(2):1228. https://doi.org/10.3390/su15021228
Desai AN, Ruidera D, Steinbrink JM, Granwehr B, Lee DH. Misinformation and Disinformation: The Potential Disadvantages of Social Media in Infectious Disease and How to Combat Them. Clin Infect Dis. 2022 May;74 Suppl_3:e34-9. https://doi.org/10.1093/cid/ciac109
Ho M, Tadrous M, Iacono A, Suda K, Gomes T. Outpatient purchasing patterns of hydroxychloroquine and ivermectin in the USA and Canada during the COVID-19 pandemic: an interrupted time series analysis from 2016 to 2021. J Antimicrob Chemother. 2022 Dec;78(1):242-51. https://doi.org/10.1093/jac/dkac382
Badell-Grau RA, Cuff JP, Kelly BP, Waller-Evans H, Lloyd-Evans E. Investigating the prevalence of reactive online searching in the COVID-19 pandemic: infoveillance study. J Med Internet Res. 2020 Oct;22(10):e19791. https://doi.org/10.2196/19791
Hentschke-Lopes M, Botton MR, Borges P, Freitas M, Mancuso AC, Matte U. Sales of “COVID kit” drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency. Cad Saude Publica. 2022 Jul;38(7):e00001022. https://doi.org/10.1590/0102-311xen001022
Oh O, Agrawal M, Rao HR. Community intelligence and social media services: a rumor theoretic analysis of tweets during social crises. Manage Inf Syst Q. 2013;37(2):407–26. https://doi.org/10.25300/MISQ/2013/37.2.05
Niburski K, Niburski O. Impact of Trump’s promotion of unproven COVID-19 treatments and subsequent internet trends: observational study. J Med Internet Res. 2020 Nov;22(11):e20044. https://doi.org/10.2196/20044
Liu M, Caputi TL, Dredze M, Kesselheim AS, Ayers JW. Internet searches for unproven COVID-19 therapies in the United States. JAMA Intern Med. 2020 Aug;180(8):1116–8. https://doi.org/10.1001/jamainternmed.2020.1764
Paiva AM, Pinto AW, Cançado BL, Chequer FM, Pereira ML, Baldoni AO. Effect of “therapeutic promises” on drug prices in times of pandemic. J Heal Biol Sci. 2020 Sep;8(1):1. https://doi.org/10.12662/2317-3076jhbs.v8i1.3407.p1-5.2020.
Geller AI, Lovegrove MC, Lind JN, Datta SD, Budnitz DS. Assessment of outpatient dispensing of products proposed for treatment or prevention of COVID-19 by US retail pharmacies during the pandemic. JAMA Intern Med. 2021 Jun;181(6):869-72.
https://doi.org/10.1001/jamainternmed.2021.0299
Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye (Lond). 2017 Jun;31(6):828-45. https://doi.org/10.1038/eye.2016.298
Mittal N, Mittal R. Inhaled route and anti-inflammatory action of ivermectin: do they hold promise in fighting against COVID-19? Med Hypotheses. 2021 Jan;146(October 2020):110364. Disponível em: https://doi.org/10.1016/j.mehy.2020.110364
Mega ER. Embrace of unproven Covid treatment hinders drug trials. Nature. 2020;586:481-2. https://doi.org/10.1038/d41586-020-02958-2
Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Giattino C, Hasell J, et al. Coronavirus pandemic (COVID-19). 2022 [citado 4 nov 2022]. Disponível em: https://ourworldindata.org/coronavirus#explore-the-global-situation
IQVIA. IQVIA Brasil. 2023 [citado 9 jan 2023]. Disponível em: https://www.iqvia.com/pt-br/locations/brazil
Alsharef A, Aggarwal K, Sonia, Kumar M, Mishra A. Review of ML and AutoML solutions to forecast time-series data. Arch Comput Methods Eng. 2022;29(7):5297-311. https://doi.org/10.1007/s11831-022-09765-0
Hair JF, Black WC, Babin BJ, Anderson RE, Tatham RL. Análise multivariada de dados. 6th ed. Porto Alegre: Bookman; 2009.
Lima CA, Calazans J HC, Dantas IH. (Des)Informação em câmaras de eco do Twitter: disputas sobre a cloroquina na pandemia da Covid-19. Rev Obs. 2020 Oct 1;6(6):1-27.
Badreldin HA, Atallah B. Global drug shortages due to COVID-19: impact on patient care and mitigation strategies. Res Social Adm Pharm. 2021 Jan;17(1):1946-9. https://doi.org/10.1016/j.sapharm.2020.05.017
Salahuddin M, Manzar D, Unissa A, Pandi-Perumal SR. BaHammam AS. The global shortage of essential drugs during the COVID-19 pandemic: evidence based on aggregated media and social media reports. J Nat Sci Med. 2022;5:23-8.
https://doi.org/10.4103/jnsm.jnsm_61_21
Watanabe P, Pamplona N. Pacientes que usam hidroxicloroquina já não acham o remédio nas farmácias. Folha de São Paulo. 19 mar 2020 [citado 12 out 2022]. Disponível em: https://www1.folha.uol.com.br/equilibrioesaude/2020/03/pacientes-que-usam-hidroxicloroquina-ja-naoacham-o-remedio-em-farmacias.shtml
Preite Sobrinho W. Com alta na procura, preço dispara e cloroquina some das farmácias. IDEC. 26 maio 2020 [citado 12 out 2022]. Disponível em: https://idec.org.br/idec-na-imprensa/comalta-na-procura-preco-dispara-e-cloroquina-some-das-farmacias
Andrade A, Lemos R. Levantamento do G1 aponta falta de hidroxicloroquina em farmácias da Zona da Mata e Vertentes. G1. 2020 Jul 20 [citado 12 out 2022]. Disponível em: https://g1.globo.com/mg/zona-da-mata/noticia/2020/07/20/levantamento-do-g1-aponta-falta-dehidroxicloroquina-em-farmacias-da-zona-da-mata-e-vertentes.ghtml
Carvalho CA, Carvalho VA, Campos MA, Oliveira BL, Diniz EM, Santos AM, et al. Delay in death reporting affects timely monitoring and modeling of the COVID-19 pandemic. Cad Saude Publica. 2021 Aug;37(7):e00292320. https://doi.org/10.1590/0102-311x00292320
Xavier F, Olenscki JR, Acosta AL, Sallum MA, Saraiva AM. Análise de redes sociais como estratégia de apoio à vigilância em saúde durante a Covid-19. Estud Av. 2020 Aug;34(99):261-82. https://doi.org/10.1590/s0103-4014.2020.3499.016
Moura EC, Cortez-Escalante J, Cavalcante FV, Barreto IC, Sanchez MN, Santos LM. Covid-19: evolução temporal e imunização nas três ondas epidemiológicas, Brasil, 2020–2022. Rev Saude Publica. 2022 Nov;56:105. https://doi.org/10.11606/s1518-8787.2022056004907
Harb M P, Veiga e Silva L, Vijaykumar N, Silva MS, Frances CRL. The COVID-19 infodemic in Brazil: trends in Google search data. PeerJ. 2022 Aug 4;10:e13747. https://doi.org/10.7717/peerj.13747. eCollection 2022
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Irineu de Brito Junior, Flaviane Azevedo Saraiva, Nathan de Campos Bruno, Roberto Fray da Silva, Celso Mitsuo Hino, Hugo Tsugunobu Yoshida Yoshizaki
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Funding data
-
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Grant numbers 404803/2021-0 -
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Grant numbers 313687/2019-6